GRI

Anmat ordered a comparability guide for the development of biosimilar products

News Healthcare & Pharma Law & Policy Updates
Date: 17th Mar, 2025 Source: National Administration of Drugs, Food and Medical Technology (ANMAT) Country: Argentina Original Source

Brief

On March 17, 2025, the National Administration of Drugs, Food and Medical Technology (ANMAT) issued an update regarding Anmat ordered a comparability guide for the development of biosimilar products. This update aims to foster accessibility in these modern medicines by focusing on product strategy within the national market, ensuring availability and a wider variety of choices for users.

This content is restricted.

Highlights content goes here...

This content is restricted.

National Administration of Drugs, Food and Medical Technology (ANMAT)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested
Related Documents
Federal Government regulates criteria for recognition of high performance entities and athletes in sports shooting
Date: 11th Apr, 2025 Source: Ministry of Justice and Public Security (MJSP) Country: Brazil
News Consumer protection Law & Policy Updates
The BCRA and the PBOC renew the activated SWAP section
Date: 10th Apr, 2025 Source: Central Bank of the Argentine Republic Country: Argentina
News Financial services Law & Policy Updates
Indigenous April: TRF1 maintains a decision that requires Ibama and Funai to protect Indigenous Land Trincheira Bacajá (PA)
Date: 9th Apr, 2025 Source: Federal Public Ministry (Ministério Público Federal – MPF) Country: Brazil
News Anti-bribery and corruption Law & Policy Updates

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Click here

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
  • Designed for Growing Compliance Teams
$125 / month OR $1250 / year
Features
  • • Coverage for 20 jurisdictions
  • • Monitoring from 500+ regulatory authorities
  • • AI compliance summaries
  • • RaDa.ai : Single-Role
Best for: Researchers, Legal professionals, Academics
Subscribe Now
Enterprise Plan
  • Perfect for Global Enterprises
Contact for Pricing
Features
  • • Custom jurisdictional coverage
  • • Custom monitoring of regulatory authorities
  • • RaDa.ai : Customizable multi-role
  • • Custom reporting and dashboard capabilities
  • • API access for seamless integration
Best for: Law Firms, Corporations, Government Bodies
Contact Sales